Pharmacology Flashcards

1
Q

FDA approved proprietary drug

A

safety and efficacy with good laboratory practices
active ingredient, product were manufactured under good lab practices in FDA inspected facilities
therapeutic consistency, product quality, accurate shelf life, scientifically substantiated labeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

brand name vs pharmaceutical ingredient

A

brand name is capitalized
ingredient is lowercase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

steps for drug approval

A
  • drug concept is formed
    • investigational new animal drug number assigned
  • dosage regimen determined
  • target animal safety (1x, 2x, 3x, 5x for 90 days)
  • effectiveness (field trial)
  • human food safety (food animal)
  • chemistry, manufacturing, controls
  • environmental impact
  • new animal drug application # (on box)
  • post-marketing surveillance
    • crucial! report adverse effects to FDA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

VPCR

A

veterinary client patient relationship

vet has examined the animal, developed a prelim diagnosis, and determined the need for the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Schedule 1 drug

A

highest potential for abuse

no medical use

lack of accepted safety

none in vet med (heroin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

schedule II drug

A

high potential for abuse

accepted for medical use with severe restrictions

may lead to severe psychological or physical dependence

morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

schedule III drug

A

potential for abuse

accepted for medical treatment

abuse may lead to moderate or low physical dependence

ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

schedule IV drug

A

potential for abuse

accepted for medical use

may lead to limited dependence

diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

schedule V drugs

A

low potential for abuse

accepted for medical use

may lead to limited dependence

gabapentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

generic drugs

A

FDA approved

ANADA abbreviated

bioequivalent

may have brand name

prescription or OTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

generic vs brand name drugs

A

generic= lower cost

different excipients (inactive ingredients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

excipients

A

inactive ingredients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

compounded drugs

A

HAVE NOT been tested for bioequivalence, efficacy, safety, strength

may not be manufactured under GMP in federally inspected plants

are NOT approved by FDA

ex: mixing injectables, crushing pills for an oral suspension

changing concentration to fit size of patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NDC numbers

A

national drug code

approved for a species, not necessarily for your species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dose

A

quantity of a medicine or drug taken at a particular time

total mg or mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dosage

A

quantity and frequency of a dose of medicine or drug

mg/kg/day, mg/kg every 12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

dosage regimen

A

includes the route of administration and duration of dosing

mg/kg IV every 12 hours for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

pharmacodynamics (PD)

A

what the drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

pharmacokinetics (PK)

A

what the body does to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

pharmacogenetics

A

how genes affect responses to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

chemotherapy

A

effect of drugs upon microorganisms, parasites, and neoplastic cells living and multiplying in an organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

toxicology/toxic effects

A

study of undesirable effects of chemicals on living systems

result from excessive pharmacological action due to overdose or prolonged usage

may occur in some patients at therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

side effects

A

drug action outside the desired site

may be good or bad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

adverse drug reaction

A

relates to change in patient

similar to adverse drug effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
adverse drug effect
relates to effect of the drug similar to adverse drug reaction
26
adverse drug event
occurs while a patient is on a drug causality has not been determined may or may not be related to drug
27
dose-response curve for most drugs
Magnitude of pharmacologic response is proportionately related to the (log of) drug concentration at the tissue (receptor) site
28
phase 2 dose response curve
linear response with desired effect
29
phase 1 dose response curve
no response observed
30
dose response curve phase 3
no increased response seen, toxic effects possible
31
ED50
Effective dose in 50% of a population
32
TD50
Toxic dose in 50% of a population
33
LD50
Lethal dose in 50% of a population
34
Therapeutic index
Ratio of TD50 to the ED50 Provides some indication of drug safety The larger (wider) the index, the safer the drug
35
A wider therapeutic index
36
most common drug receptor
GPCRs increase/decrease enzyme activity
37
tachyphylaxis
acute tolerance of a drug after only a few doses need break from the drug for it to work
38
tolerance
* Decreasing response to repeated constant doses of a drug * May be pharmacokinetic or dynamic ex: opioid
39
affinity
• Force of attraction between drug and receptor • Higher affinity drugs are harder to displace works for longer, needs higher, more frequent doses of reversal
40
selectivity
Specificity of the drug for the target receptor binding ex: epinephrine (least selective) binds to most sympathetic receptors while dobutamine (more selective) only binds to 2
41
why is selectivity important?
* Stronger effects on the target receptor * Fewer effects on unwanted receptors (side effects)
42
potency
* Comparative term * Describes the concentration of different drugs necessary to induce the same magnitude of response
43
True or False: A more potent drug is a better drug.
false
44
efficacy
MOST IMPORTANT intrinsic activity ability of a drug to have a response complex relationship btwn drug concentration, receptor activation, cellular response
45
agonist
receptor interaction results in activation magnitude of effect is proportional to the # of receptors occupied
46
partial agonist
binds and activates a receptor only results in partial response maximal response not observed lower efficacy
47
antagonist
drug interacts selectively with receptor but it lacks intrinsic efficacy blocks or reduces action of an agonist at the receptor
48
competitive vs non competitive antagonists
* Competitive: Looks like the drug– binds at the same site * Non-competitive: Binds somewhere else (allosteric site), Changes receptor conformation so the agonist can’t bind usually to reverse agonist drugs
49
reversible antagonists
• Binds to receptor (affinity) but can easily dissociate from the receptor • H-bonds, van der waals = all weak/reversible • Agonist present at sufficiently high concentrations can displace an antagonist • Decreases potency because a higher concentration is now necessary to induce the same response
50
irreversible antagonist
Binds and stays • Covalent bonds • Agonist response can not occur until the receptor is replaced and any remaining unbound antagonist has been removed from the body • Decreases efficacy preventing the maximal possible response
51
inverse agonists
bind and has negative response confused with antagonist in literature
52
chemical antagonism
Direct chemical interaction between two drugs (i.e., a weak acid and weak base)
53
physiologic antagonism
Two drugs act in the same physiologic system but act on different receptors or pathways
54
pharmacokinetic antagonism
One drug alters the response to another drug through changes in disposition
55
molecular weight affect on drug transfer
smaller = increased
56
lipid solubility affect on drug transfer
higher solubility = higher transfer
57
pKa affect on drug transfer
unionized= higher transfer
58
protein binding affect on drug transfer
lower = higher drug transfer
59
concentration gradient affect on drug transfer
higher= higher drug transfer
60
end receptor for parasympathetic NS
muscarinic
61
end receptor for sympathetic NS
adrenergic
62
neurotransmitters for the PNS
acetylcholine
63
SNS neurotransmitters
norepinephrine, epinephrine (from adrenal gland)
64
parasympatho***mimetic***
aka cholinergic agonists at muscarinic receptors in PNS mimic ACh
65
parasympatho***lytic***
antagonists at muscarinic receptors aka anticholinergic block ACh
66
M1 receptors effect:
forebrain, PNS effector cells, gastric mucosa, neurons, cerebral cortex
67
M2 receptors effects:
heart, PNS effector cells, cardiac muscles
68
M3 receptors effect
smooth muscle, exocrine intestinal smooth muscle and glands
69
M4 receptors
neostriatum, spinal cord, involved in pain
70
M5 receptors
brain, dopamine response
71
classes of Parasympathomimetic drugs
Cholinergic agonists Anticholinesterases
72
Cholinergic agonists
Mimic the action of acetylcholine
73
Anticholinesterases
Inhibit the destruction of acetylcholine by blocking acetylcholinesterase
74
In general, parasympathomimetic drugs stimulate muscles to contract or relax in target organs? What are the exceptions?
contract ## Footnote S alivation L acrimation U rination D efecation D igestion except HR- slows HR, slow breathing
75
clinical uses of parasympathomimetic drugs
* Stimulate GI motility and gastric emptying * Stimulate bladder emptying * Constrict the pupil (some forms of glaucoma)
76
In general, parasympatholytic drugs relax or contract muscles in target organs?
Relax ## Footnote **A** nhidrosis (lack of sweating) **B** lurry vision (mydriasis/dry eye) **D** ry mouth (decreased salivation) **U** rine retention **C** onstipation (ileus) **T** achycardia
77
parasympatholytic drugs clinical uses
* Cause bronchodilation * Stop diarrhea * Antiemetics (stop vomiting) * Cause mydriasis (pupil dilation) * Treat bradycardia (low heart rate)
78
major subtypes of sympathetic drugs
alpha adrenergic (a1 and a2) beta adrenergic (b1 and b2)
79
sympatho***mimetics***
agonists at these receptors adrenergic agonists
80
sympatho***lytics***
adrenergic antagonists/blockers Drugs that act as antagonists Block the actions of the sympathetic nervous system Most drugs in this class will be specific for either alpha or beta receptors
81
3 classes of sympathomimetic drugs
direct acting indirect acting dual acting
82
direct acting sympathomimetic drugs
Directly stimulate adrenergic receptors
83
indirect acting sympathomimetic drugs
Stimulate the release of NE from nerve endings in the synapse
84
dual acting sympathomimetic drugs
Directly stimulate adrenergic receptors and Stimulate the release of NE from nerve endings in the synapse
85
alpha 1 adrenergic receptor
main location: blood vessels, eye main agonist actions: vasoconstriction, pupil dilation main clinical uses: hypotension, antiarrhythmic, mydriasis main adverse effects: Hypertension, Arrhythmias, CNS stimulation
86
alpha 2 agonist drugs
main location: CNS, pancreas main agonist actions: Decreased sympathetic outflow, Decreased NE release, Decreased insulin secretion main clinical uses: sedative, analgesic, muscle relaxation, anxiolysis main adverse effects: Initial hypertension which results in baroreceptor-mediated reflex bradycardia (As the peripheral effects diminish, central alpha-2 actions predominate, leading to decreased blood pressure and cardiac output) • Arrhythmias • Vomiting (particularly in cats!) • Increased urine output • Transient hyperglycemia • Increased myometrial tone and intrauterine pressure 25 \*\*\*stim of alpha 2 cause sympathetic inhibition!!
87
beta 1 adrenergic agonist drugs
main location: heart, kidney main agonist actions: increased HR, increased heart contractility, increased renin release main clinical uses: hypotension, anesthesia/shock, bradycardia main adverse effects: hypertension, tachycardia, arrhythmias
88
beta 2 adrenergic agonist drugs
main location: lungs (we have 2 lungs), uterus, blood vessels (but not brain/skin main agonist actions: bronchodilation, uterine relaxation, vasodilation main clinical uses: Respiratory disease/asthma, Delaying parturition main adverse effects: Tachycardia/myocardial necrosis, CNS excitement, Muscle tremors
89
alpha 1 antagonists
• Treat congestive heart failure/hypertension; urine retention
90
alpha 2 antagonists
Reverse the sedation and bradycardic effects of alpha-2 agonists
91
beta 1 antagonists
treat congestive heart failure
92
beta 2 antagonists
* No specific uses * Most beta-1 antagonists have beta-2 antagonist ability • Use with caution in asthmatic patients (cause bronchoconstriction)